Pharmaids Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
as on 22-12-2024
- Paid Up Capital ₹ 35.27 Cr
as on 22-12-2024
- Company Age 35 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.85 Cr
as on 22-12-2024
- Revenue -53.90%
(FY 2022)
- Profit 55.55%
(FY 2022)
- Ebitda 28.22%
(FY 2022)
- Net Worth 1.70%
(FY 2022)
- Total Assets 21.91%
(FY 2022)
About Pharmaids Pharmaceuticals
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524572.
The Corporate was formerly known as Pharmaids Pharmacuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 45.00 Cr and a paid-up capital of Rs 35.27 Cr.
The company has closed loans amounting to ₹1.85 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Pharmaids Pharmaceuticals Limited India are Balagangadhara Channathimmaiah as Cfo, Prasanna Bhat as Company Secretary, and Shivarudraiah Prasad as Ceo. Venu Kaparthy, Pattamadai Vijay, Mopperthy Sudheer, and Four other members serve as directors at the Company.
- CIN/LLPIN
L52520KA1989PLC173979
- Company No.
009679
- Stock Symbol
BSE : 524572
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Mar 1989
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pharmaids Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balagangadhara Channathimmaiah | CFO | 13-Oct-2022 | Current |
Prasanna Bhat  | Company Secretary | 26-Aug-2024 | Current |
| Shivarudraiah Prasad | CEO | 29-Jan-2024 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venu Kaparthy | Whole-Time Director | 21-May-2022 | Current |
| Pattamadai Vijay | Director | 31-Oct-2022 | Current |
| Mopperthy Sudheer | Director | 06-Jan-2021 | Current |
| Shankarappa Babu | Director | 31-Jan-2024 | Current |
| Methuku Nagesh | Director | 29-Nov-2022 | Current |
| Shreedhara Shetty | Director | 29-Aug-2023 | Current |
Financial Performance of Pharmaids Pharmaceuticals.
Pharmaids Pharmaceuticals Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 53.9% decrease. The company also saw a substantial improvement in profitability, with a 55.55% increase in profit. The company's net worth moved up by a moderate rise of 1.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmaids Pharmaceuticals?
In 2023, Pharmaids Pharmaceuticals had a promoter holding of 9.95% and a public holding of 90.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Religent Global Ventures Private LimitedActive 11 years 7 monthsShreedhara Shetty is a mutual person
Innovalus Technologies Private LimitedActive 13 years 11 monthsShreedhara Shetty is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Sep 2015 | ₹1.00 Cr | Satisfied |
Central Bank Of India Creation Date: 10 Sep 1996 | ₹0.50 M | Satisfied |
Central Bank Of India Creation Date: 31 Jul 1995 | ₹3.00 M | Satisfied |
How Many Employees Work at Pharmaids Pharmaceuticals?
Unlock and access historical data on people associated with Pharmaids Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmaids Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaids Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
